A. Nakano

发表

BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma

M. Abe, S. Kido, M. Hiasa, 2006, Leukemia.

Induction of endoplasmic reticulum stress by bortezomib sensitizes myeloma cells to DR5-mediated cell death

S. Iida, Toshio Matsumoto, M. Abe, 2015 .

Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL

K. Yata, Toshio Matsumoto, M. Abe, 2012, PloS one.

Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma

Toshio Matsumoto, M. Abe, A. Nakano, 2011, International journal of hematology.

Expressions of matrilysin and stromelysin in human glioma cells.

J. Furuyama, K. Miyazaki, A. Nakano, 1993, Biochemical and biophysical research communications.

of TNF-{alpha} converting enzyme (TACE) osteoclastogenesis through M-CSF receptor shedding by up-regulation GM-CSF and IL-4 induce dendritic cell differentiation and disrupt

K. Moriyama, K. Yata, Toshio Matsumoto, 2009 .

GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE).

K. Moriyama, K. Yata, Toshio Matsumoto, 2009, Blood.

Targeting myeloma–osteoclast interaction with Vγ9Vδ2 T cells

K. Yata, Toshio Matsumoto, M. Abe, 2011, International journal of hematology.

Delayed treatment with vitamin C and N-acetyl-l-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib

Toshio Matsumoto, Takashi Watanabe, M. Abe, 2011, International journal of hematology.

Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity.

H. Okano, S. Sakakibara, M. Yamasaki, 2001, Differentiation; research in biological diversity.

Inhibition by 5'-methylthioadenosine of cell growth and tyrosine kinase activity stimulated by fibroblast growth factor receptor in human gliomas.

A. Nakano, H. Ikemoto, E. Tani, 1995, Journal of neurosurgery.

Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.

A. Nakano, E. Tani, H. Shindo, 1994, Journal of neurosurgery.

Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin

K. Moriyama, Toshio Matsumoto, M. Abe, 2007, Clinical Cancer Research.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.

J. Furuyama, K. Miyazaki, A. Nakano, 1995, Journal of neurosurgery.

KRN5500, a spicamycin derivative, exerts anti‐myeloma effects through impairing both myeloma cells and osteoclasts

K. Yata, Toshio Matsumoto, M. Abe, 2011, British journal of haematology.

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors

D. Tsuji, S. Nakamura, M. Abe, 2012, Leukemia.

Role of Ras Signaling in the Induction of Snail by Transforming Growth Factor-β*

Takeshi Imamura, Kohei Miyazono, K. Miyazono, 2009, Journal of Biological Chemistry.

Expression of the Neural RNA-Binding Protein Musashi1 in Pediatric Brain Tumors

H. Okano, M. Yamasaki, Y. Kanemura, 2007, Pediatric Neurosurgery.

Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor.

J. Furuyama, A. Nakano, H. Ikemoto, 1995, Journal of neurosurgery.

Pin1 Down-regulates Transforming Growth Factor-β (TGF-β) Signaling by Inducing Degradation of Smad Proteins*

K. Miyazono, H. Akiyama, T. Uchida, 2009, Journal of Biological Chemistry.

Chondromyxoid fibroma of the frontal bone.

A. Nakano, E. Tani, T. Morimura, 1992, AJNR. American journal of neuroradiology.

Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib

Toshio Matsumoto, M. Abe, S. Kido, 2013, International Journal of Hematology.

Cerebrospinal fluid leakage from the nipple after ventriculoperitoneal shunt: case report.

A. Nakano, E. Tani, A. Nakano, 1994, Surgical neurology.

TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth

K. Yata, Toshio Matsumoto, M. Abe, 2010, PloS one.

Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells

Toshio Matsumoto, D. Tsuji, M. Abe, 2011, PloS one.

Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma

Toshio Matsumoto, M. Abe, M. Hiasa, 2009, International journal of hematology.

Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate

Toshio Matsumoto, M. Abe, A. Nakano, 2012, Journal of Bioenergetics and Biomembranes.

Endovascular treatment of ruptured dissecting aneurysms aimed at occlusion of the dissected site by using Guglielmi detachable coils.

A. Nakano, E. Tani, M. Yokota, 1999, Journal of neurosurgery.

The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells

I. Endo, K. Yata, S. Nakamura, 2011, Leukemia.

Solitary plasmacytoma with VEGF overproduction: Report of a patient with polyneuropathy

I. Endo, T. Mitsui, A. Nakano, 2001, Neurology.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.

J. Furuyama, K. Miyazaki, A. Nakano, 1995, Journal of neurosurgery.

Pin1 Down-regulates Transforming Growth Factor-β (TGF-β) Signaling by Inducing Degradation of Smad Proteins*

K. Miyazono, H. Akiyama, T. Uchida, 2009, Journal of Biological Chemistry.

KRN5500, a Spicamycin Derivative, Exerts Anti-Myeloma Effects through Impairing Both Myeloma Cells and Osteoclasts.

K. Yata, Toshio Matsumoto, M. Abe, 2008 .